Stock HSM HELIUS MEDICAL TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Helius Medical Technologies, Inc. Toronto S.E.

Equities

HSM

US42328V1089

Advanced Medical Equipment & Technology

Delayed Toronto S.E.
Other stock markets
 		5-day change 1st Jan Change
- CAD -.--% Intraday chart for Helius Medical Technologies, Inc. +4.21% -.--%
17/06 Helius Medical Technologies, Inc. Completes Site Participation Enrollment for Its U.S. Registrational Program in Stroke CI
20/05 Helius Medical Technologies, Inc. Announces Pons Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule and General Services Administration Advantage Contracts CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 29.8 19.57 20.66 8.656 5.694 2.904 -
Enterprise Value (EV) 1 29.8 19.57 20.66 8.656 5.694 2.904 2.904
P/E ratio -2.62 x -1.12 x -0.7 x -0.3 x -0.55 x -0.18 x -0.33 x
Yield - - - - - - -
Capitalization / Revenue 19.9 x 29.6 x 39.6 x 11 x 8.84 x 4.13 x 2.22 x
EV / Revenue 19.9 x 29.6 x 39.6 x 11 x 8.84 x 4.13 x 2.22 x
EV / EBITDA - - - - - - -
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 17.6 29.7 79.6 564 708 2,963 -
Reference price 2 1,698 659.1 259.5 15.34 8.039 0.9800 0.9800
Announcement Date 12/03/20 10/03/21 14/03/22 09/03/23 28/03/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 1.496 0.661 0.522 0.787 0.644 0.703 1.306
EBITDA - - - - - - -
EBIT 1 -24 -14.39 -18.14 -15.52 -12.43 -13.49 -13.85
Operating Margin -1,604.01% -2,176.4% -3,475.48% -1,971.54% -1,929.81% -1,918.49% -1,060.72%
Earnings before Tax (EBT) 1 -9.781 -14.13 - -14.07 -8.85 -10.37 -14.9
Net income 1 -9.781 -14.13 -18.16 -14.07 -8.85 -10.37 -14.9
Net margin -653.81% -2,137.67% -3,478.54% -1,788.06% -1,374.22% -1,475.25% -1,140.96%
EPS 2 -647.5 -590.0 -369.0 -52.00 -14.56 -5.470 -3.010
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 12/03/20 10/03/21 14/03/22 09/03/23 28/03/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 0.258 0.19 0.119 0.196 0.282 0.111 0.256 0.143 0.134 0.135 0.15 0.15 0.268
EBITDA - - - - - - - - - - - - -
EBIT 1 -4.102 -4.564 -3.43 -4.853 -2.669 -3.81 -3.219 -3.153 -2.246 -3.416 -3.29 -3.362 -3.419
Operating Margin -1,589.92% -2,402.11% -2,882.35% -2,476.02% -946.45% -3,432.43% -1,257.42% -2,204.9% -1,676.12% -2,530.37% -2,193.33% -2,241.33% -1,275.75%
Earnings before Tax (EBT) 1 - - -3.81 -1.03 -4.886 -2.494 -1.648 -3.663 -1.045 -2.516 -1.182 -3.29 -3.383
Net income 1 -4.102 -4.346 -3.81 -1.03 -4.886 -2.494 -1.648 -3.663 -1.045 -2.516 -1.182 -3.29 -3.383
Net margin -1,589.92% -2,287.37% -3,201.68% -525.51% -1,732.62% -2,246.85% -643.75% -2,561.54% -779.85% -1,863.7% -788% -2,193.33% -1,262.31%
EPS 2 -65.50 -57.50 -48.50 -6.000 -8.500 -4.500 -3.000 -5.490 -0.9600 -3.080 -0.5000 -0.9800 -0.9200
Dividend per Share - - - - - - - - - - - - -
Announcement Date 14/03/22 12/05/22 15/08/22 14/11/22 09/03/23 11/05/23 10/08/23 09/11/23 28/03/24 13/05/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - 0.06 0.05 0.02 0.03 - -
Capex / Sales - 9.53% 10.34% 2.16% 4.5% - -
Announcement Date 12/03/20 10/03/21 14/03/22 09/03/23 28/03/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Helius Medical Technologies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.98 USD
Average target price
4 USD
Spread / Average Target
+308.16%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+4.18% 211B
DANAHER CORPORATION Stock Danaher Corporation
+8.00% 185B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+31.86% 158B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+33.21% 113B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.28% 64.32B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+21.14% 55.66B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+0.11% 48.41B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-6.76% 37.82B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.78% 35.57B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. HSDT Stock
  4. HSM Stock
  5. Financials Helius Medical Technologies, Inc.